VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $698,000 | +39.9% | 53,151 | +2.9% | 0.06% | +7.4% |
Q3 2020 | $499,000 | +136.5% | 51,630 | +180.3% | 0.05% | +54.3% |
Q2 2020 | $211,000 | -43.7% | 18,418 | -49.1% | 0.04% | -22.2% |
Q1 2020 | $375,000 | -0.3% | 36,218 | +58.1% | 0.04% | +45.2% |
Q4 2019 | $376,000 | -45.4% | 22,911 | -55.9% | 0.03% | -26.2% |
Q3 2019 | $689,000 | +44.4% | 51,900 | +100.4% | 0.04% | -41.7% |
Q1 2019 | $477,000 | – | 25,900 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |